The Use of Imatinib Mesylate as a Lifesaving Treatment of Chronic Myeloid Leukemia Relapse after Bone Marrow Transplantation

We describe the response of imatinib as lifesaving treatment of chronic myeloid leukemia (CML) relapse in seven patients who underwent allogeneic bone marrow transplantation (alloBMT) at our institution over a period of 4 years. Retrospective analysis of their medical records revealed that a mean ag...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Conchon, Monika, Sanabani, Sabri S., Bendit, Israel, Dinardo, Carla Luana, Dias, Lucia, Chamone, Dalton de Alencar Fischer, Dorlhiac-Llacer, Pedro Enrique, Dulley, Frederico Luiz
Format: Artigo
Jezik:Inglês
Izdano: Hindawi Publishing Corporation 2009
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2809434/
https://ncbi.nlm.nih.gov/pubmed/20107580
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2009/357093
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki